The electricity generator and retailer has no immediate need for new equity but has potential for significant further investment, says Forsyth Barr.
The company is developing a biological electronic nose that can detect human diseases.
US Food & Drug Administration exercises enforcement discretion for A2 Milk’s infant formula made by Synlait.
Media company to return $70m to investors, raise dividend range, and launch buyback.
The tourism company told shareholders it's frustrated it took nine months to get the merger green-lit by trans-Tasman regulators
‘I don’t see my leaving having any influence on the business,’ Brent King tells NBR.
In parting shot, Grant Rosewarne criticised time taken to get through ocean farming resource consent process.
ForBar has also lowered its earnings forecast and target price for the country’s biggest port.
Investors respond to $1.34 a share takeover offer Pushpay’s board recommended late Friday.
A consortium of BGH Capital and Sixth Street, which own 20.3% of Pushpay, offer $1.34 a share.
